NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+1-905-6293822
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Novadaq Technologies (NASDAQ:NVDQ) Frequently Asked Questions
What is Novadaq Technologies' stock symbol?
Novadaq Technologies trades on the NASDAQ under the ticker symbol "NVDQ."
How were Novadaq Technologies' earnings last quarter?
Novadaq Technologies Inc. (NASDAQ:NVDQ) issued its earnings results on Wednesday, May, 3rd. The medical research company reported ($0.24) EPS for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.03. The medical research company had revenue of $21.08 million for the quarter, compared to analyst estimates of $20.12 million. View Novadaq Technologies' Earnings History.
Has Novadaq Technologies been receiving favorable news coverage?
Press coverage about NVDQ stock has been trending positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Novadaq Technologies earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days.
What other stocks do shareholders of Novadaq Technologies own?
Who are Novadaq Technologies' key executives?
Novadaq Technologies' management team includes the folowing people:
- William A. MacKinnon, Chairman of the Board
- Rick Mangat Ph.D., President, Chief Executive Officer
- , Bio & Compensation -
- Roger Deck, Chief Financial Officer
- , Bio & Compensation -
- Lori Swalm, Vice President of Marketing
- , Bio & Compensation -
- Derrick Guo, General Counsel, Corporate Secretary
- , Bio & Compensation -
- Anthony F. Griffiths, Lead Independent Director
- Lisa N. Colleran, Director
- Karen A. Licitra, Director
- , Bio & Compensation -
- Patrice E. Merrin, Independent Director
- Thomas G. Wellner, Independent Director
How do I buy shares of Novadaq Technologies?
Shares of NVDQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Novadaq Technologies' stock price today?
One share of NVDQ stock can currently be purchased for approximately $11.75.
What is Novadaq Technologies' official website?
How can I contact Novadaq Technologies?
Novadaq Technologies' mailing address is 5090 Explorer Dr Suite 202, MISSISSAUGA, ON L4W 4T9, Canada. The medical research company can be reached via phone at +1-905-6293822.
MarketBeat Community Rating for Novadaq Technologies (NASDAQ NVDQ)
MarketBeat's community ratings are surveys of what our community members think about Novadaq Technologies and other stocks. Vote "Outperform" if you believe NVDQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVDQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
